サインイン 無料でサインアップします。

Acorda Therapeutics IncのEPS Q / Q

Acorda Therapeutics IncのEPS Q / Qは何ですか。

Acorda Therapeutics IncのEPS Q / Qは3.62%です。

EPS Q / Qの定義は何ですか。



四半期EPS成長率(Quarterly EPS growth rate)は、過去4四半期の業績と比較して過去4四半期のEPSの増加です。

The earnings per share growth rate is an important factor for judging a company's value. EPS growth rate gives a good picture of the rate at which the company has grown its profitability in respect to the total number of shares. Comparing EPS history with stock price history helps determine the most likely future direction of the stock price.

Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.

NASDAQのセクタHealth CareにおけるEPS Q / Qの企業と比べるAcorda Therapeutics Inc

Acorda Therapeutics Incは何をしますか。

acorda therapeutics is a publicly traded (nasdaq: acor) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. we started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. we have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions. we achieve our goals by: • investing in research and development • collaborating closely with the patient, medical and scientific communities • retaining employees with compassion and commitment acorda has been voted one of the best companies to work for in new york for the past five years in a row, as a result of our dynamic environment, strong corporate

Acorda Therapeutics Incと類似のeps q / q